CLINICAL_TRIALS ClinicalTrials.gov record update

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01332929
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:26.542177+00:00
Published At: 2013-09-12T00:00:00+00:00
Record Updated At: 2013-09-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Malignant Neoplasm to Brain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-09-12"
protocolSection.identificationModule.nctId: "NCT01332929"
protocolSection.identificationModule.officialTitle: "Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin\u00ae) for Treatment of Brain Metastasis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.